ID

26109

Beschreibung

Study ID: 101468/219 Clinical Study ID: 101468/219 Study Title:An open label, randomised, five-way crossover single-dose pharmacokinetic study to assess dosage strength equivalence of ropinirole CR in healthy male and female volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Parkinson Disease Documentation part: Concomitant Medication

Stichworte

  1. 09.10.17 09.10.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

9. Oktober 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Dose strength equivalence of ropinirole CR in healthy adults Concomitant Medication 101468/219

Concomitant Medication Dose strength equivalence of ropinirole CR in healthy adults 101468/219

Concomitant Medication
Beschreibung

Concomitant Medication

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0244821
Are there any concomitant medication CHANGES since the start of the study?
Beschreibung

If ’YES’, please record all medications used below. Where appropriate, medical conditions should be recorded on the Adverse Events Form, utilizing the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.

Datentyp

boolean

Alias
UMLS CUI [1]
C2347852
drug name
Beschreibung

Trade Name Preferred

Datentyp

text

Alias
UMLS CUI [1,1]
C2360065
UMLS CUI [1,2]
C2347852
Single Dose/Unit
Beschreibung

dose per unit

Datentyp

integer

Alias
UMLS CUI [1,1]
C3174092
UMLS CUI [1,2]
C2347852
Frequency of this Dose
Beschreibung

medication frequency

Datentyp

text

Alias
UMLS CUI [1,1]
C3476109
UMLS CUI [1,2]
C2347852
Route
Beschreibung

drug application route

Datentyp

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C2347852
Indication
Beschreibung

medication indication

Datentyp

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C2347852
Duration
Beschreibung

duration of medication

Datentyp

text

Alias
UMLS CUI [1,1]
C0449238
UMLS CUI [1,2]
C2347852
End Date
Beschreibung

end date of medication

Datentyp

date

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0806020
Continuing at end of study?
Beschreibung

continuing medication

Datentyp

boolean

Alias
UMLS CUI [1]
C2826666

Ähnliche Modelle

Concomitant Medication Dose strength equivalence of ropinirole CR in healthy adults 101468/219

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
C0244821 (UMLS CUI-2)
concomitant medication
Item
Are there any concomitant medication CHANGES since the start of the study?
boolean
C2347852 (UMLS CUI [1])
drug name
Item
drug name
text
C2360065 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
dose per unit
Item
Single Dose/Unit
integer
C3174092 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
medication frequency
Item
Frequency of this Dose
text
C3476109 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
drug application route
Item
Route
text
C0013153 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
medication indication
Item
Indication
text
C3146298 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
duration of medication
Item
Duration
text
C0449238 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
end date of medication
Item
End Date
date
C2347852 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
continuing medication
Item
Continuing at end of study?
boolean
C2826666 (UMLS CUI [1])

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video